Market Place
Sourcing Support
Jazz Pharma To Release Q1 Financial Results On May 5, 2026
22 Apr 2026 //
PR NEWSWIRE
Why Molecular Testing Is Key to Brain Cancer Diagnosis
20 Apr 2026 //
FIERCE PHARMA
Jazz Pharmaceuticals to Present at Needham Healthcare Conference
02 Apr 2026 //
PR NEWSWIRE
ANA, Jazz Launch Sodium Reduction, CV Health Initiative
24 Mar 2026 //
PR NEWSWIRE
Jazz Pharma Reveals 2025 Financials, Offers 2026 Guidance
24 Feb 2026 //
PR NEWSWIRE
Jazz Pharma To Join Investor Conferences
17 Feb 2026 //
PR NEWSWIRE
Jazz Pharma Announces Q4, FY 2025 Results on Feb. 24, 2026
10 Feb 2026 //
PR NEWSWIRE
JPM26: Jazz Inks $200M Priority Review Voucher Sale
14 Jan 2026 //
FIERCE PHARMA
Jazz Pharma Names Thomas Riga as Chief Business Officer
08 Jan 2026 //
PR NEWSWIRE
Jazz Pharmaceuticals To Participate In Upcoming Investor Events
17 Dec 2025 //
PR NEWSWIRE
Jazz Pharma Joins Citi`s 2025 Global Healthcare Conference
19 Nov 2025 //
PR NEWSWIRE
Jazz Pharma Reveals Q3 2025 Financials, Adjusts 2025 Guidance
05 Nov 2025 //
PR NEWSWIRE
Jazz Pharma Appoints Ted W. Love, M.D., To Board
29 Oct 2025 //
PR NEWSWIRE
Avadel And Jazz Pharma Reach Global Settlement
22 Oct 2025 //
GLOBENEWSWIRE
Jazz Pharma To Release Q3 Financial Results On Nov 5, 2025
22 Oct 2025 //
PR NEWSWIRE
Iambic Collaborates With Jazz Pharma On Her2+ Breast Cancer Study
21 Oct 2025 //
BUSINESSWIRE
Jazz Pharma Presents Xywav® Phase 4 Data At Congress
22 Sep 2025 //
PR NEWSWIRE
Jazz Pharma to Join 2025 Wells Fargo Healthcare Conference
21 Aug 2025 //
PR NEWSWIRE
Jazz inks $1B+ Deal for Saniona`s Preclinical Epilepsy Candidate
21 Aug 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals` Modeyso Webcast on August 27, 2025
20 Aug 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals Updates 2025 Financial Guidance, Q2 Results
06 Aug 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals to Report Q2 Financial Results on August 5
22 Jul 2025 //
PR NEWSWIRE
UK Watchdog Rebukes Jazz Twice Over Marketing
11 Jul 2025 //
FIERCE PHARMA
Chord change at Jazz as Renee Gala replaces Bruce Cozadd as CEO
10 Jul 2025 //
FIERCE PHARMA
Avadel Wins Appeal Upholding FDA Nod for Lumryz
30 Jun 2025 //
GLOBENEWSWIRE
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data on Xywav
09 Jun 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals Reports Long-Term Survival Data for Ziihera
02 Jun 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals to Present Research on Xywav at SLEEP 2025
28 May 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals at June Investor Conferences
21 May 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals Reports Q1 2025 Results and Updates Guidance
06 May 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals at BofA Securities 2025 Healthcare Conf
30 Apr 2025 //
PR NEWSWIRE
Jazz Pharma at 24th Annual Needham Virtual Health Conference
26 Mar 2025 //
PR NEWSWIRE
Chimerix had 8 suitors: Why Jazz won out
21 Mar 2025 //
FIERCE BIOTECH
Jazz Pharma to Present Xywav® and Epidiolex® at AAN Meeting
19 Mar 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals to buy Chimerix for $935 million
06 Mar 2025 //
PRESS RELEASE
Jazz Pharmaceuticals Reports Q4 2024 Financials, 2025 Guidance
25 Feb 2025 //
PR NEWSWIRE
Jazz Pharma To Join TD Cowen`s 45th Annual Health Care Conference
20 Feb 2025 //
PR NEWSWIRE
Jazz Pharma To Announce Q4 & Full-Year 2024 Results On Feb 25, 2025
12 Feb 2025 //
PR NEWSWIRE
Jazz Pharma to Report 2024 Full Year & Q4 Financial Results
11 Feb 2025 //
PR NEWSWIRE
Jazz hunts for new CEO as longtime chief Cozadd eyes retirement
17 Dec 2024 //
FIERCE PHARMA
Jazz Pharma to Present at the 43rd Annual J.P. Morgan Conference
17 Dec 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Announces CEO Succession Plan
16 Dec 2024 //
#N/A
Jazz Pharma To Showcase Epidiolex Benefits For Resistant Epilepsies
06 Dec 2024 //
PR NEWSWIRE
Jazz Pharma to Attend Citi`s 2024 Global Healthcare Conference
19 Nov 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Announces Q3 2024 Financial Results
06 Nov 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Presents Xywav® Data at Psych Congress 2024
31 Oct 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals To Report Q3 2024 Financial Results On Nov 6
23 Oct 2024 //
PR NEWSWIRE
Denmark`s Lundbeck bets on epilepsy drug with $2.6 bln Longboard deal
15 Oct 2024 //
REUTERS
Jazz Pharma To Present Solid Tumor Research At ESMO 2024
09 Sep 2024 //
PR NEWSWIRE
Jazz Pharma Presents Data on Epidiolex® at European Epilepsy Congress 2024
05 Sep 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Announces Pricing of $850M Notes and Share Repurchases
03 Sep 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Announces $850M Senior Notes Offering and Repurchase
03 Sep 2024 //
PR NEWSWIRE
Jazz, Hikma must face `reverse payment` claims over narcolepsy drug
27 Aug 2024 //
REUTERS
Jazz Pharma Updates On Cannabidiol Trial In Japan For Epilepsy
22 Aug 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
21 Aug 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Reports Q2 2024 Results, Updates 2024 Guidance
31 Jul 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Shareholders Elect Laura Hamill To Board
25 Jul 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Completes Loan Repricing And Note Settlement
22 Jul 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals To Report Q2 2024 Results On July 31
17 Jul 2024 //
PR NEWSWIRE
Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
09 Jul 2024 //
PR NEWSWIRE
